高风险急性早幼粒细胞白血病治疗的多中心回顾性评价：来自HERO联盟的真实世界结果

IF 9.9 1区医学 Q1 HEMATOLOGY

American Journal of Hematology Pub Date : 2025-03-26 DOI:10.1002/ajh.27667

Lydia L. Benitez, Kayleigh R. Marx, Caitlin R. Rausch, Kaitlyn M. Buhlinger, Stephen M. Clark, Justin H. Reid, Mimi Lo, Katie S. Gatwood, Sarah Profitt, Richa Shah, Jenna Ciervo, Jeffrey Baron, Bernard L. Marini, Anthony J. Perissinotti, Ashley Soule, Madeline Waldron, Benyam Muluneh

{"title":"高风险急性早幼粒细胞白血病治疗的多中心回顾性评价：来自HERO联盟的真实世界结果","authors":"Lydia L. Benitez, Kayleigh R. Marx, Caitlin R. Rausch, Kaitlyn M. Buhlinger, Stephen M. Clark, Justin H. Reid, Mimi Lo, Katie S. Gatwood, Sarah Profitt, Richa Shah, Jenna Ciervo, Jeffrey Baron, Bernard L. Marini, Anthony J. Perissinotti, Ashley Soule, Madeline Waldron, Benyam Muluneh","doi":"10.1002/ajh.27667","DOIUrl":null,"url":null,"abstract":"<p>Estimated 36-month Survival Comparison between ATRA/ATO/GO and APML4 regimens.\n <figure>\n <div><picture>\n <source></source></picture><p></p>\n </div>\n </figure>\n </p>","PeriodicalId":7724,"journal":{"name":"American Journal of Hematology","volume":"100 6","pages":"1094-1097"},"PeriodicalIF":9.9000,"publicationDate":"2025-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajh.27667","citationCount":"0","resultStr":"{\"title\":\"Multicenter Retrospective Evaluation of Treatment for High-Risk Acute Promyelocytic Leukemia: Real-World Outcomes From the HERO Consortium\",\"authors\":\"Lydia L. Benitez, Kayleigh R. Marx, Caitlin R. Rausch, Kaitlyn M. Buhlinger, Stephen M. Clark, Justin H. Reid, Mimi Lo, Katie S. Gatwood, Sarah Profitt, Richa Shah, Jenna Ciervo, Jeffrey Baron, Bernard L. Marini, Anthony J. Perissinotti, Ashley Soule, Madeline Waldron, Benyam Muluneh\",\"doi\":\"10.1002/ajh.27667\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Estimated 36-month Survival Comparison between ATRA/ATO/GO and APML4 regimens.\\n <figure>\\n <div><picture>\\n <source></source></picture><p></p>\\n </div>\\n </figure>\\n </p>\",\"PeriodicalId\":7724,\"journal\":{\"name\":\"American Journal of Hematology\",\"volume\":\"100 6\",\"pages\":\"1094-1097\"},\"PeriodicalIF\":9.9000,\"publicationDate\":\"2025-03-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ajh.27667\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Hematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/ajh.27667\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Hematology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ajh.27667","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

ATRA/ATO/GO与APML4方案的36个月生存率比较

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Multicenter Retrospective Evaluation of Treatment for High-Risk Acute Promyelocytic Leukemia: Real-World Outcomes From the HERO Consortium

查看原文本刊更多论文

Multicenter Retrospective Evaluation of Treatment for High-Risk Acute Promyelocytic Leukemia: Real-World Outcomes From the HERO Consortium

Estimated 36-month Survival Comparison between ATRA/ATO/GO and APML4 regimens.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

American Journal of Hematology 医学-血液学

CiteScore

15.70

自引率

3.90%

发文量

363

审稿时长

3-6 weeks

期刊介绍： The American Journal of Hematology offers extensive coverage of experimental and clinical aspects of blood diseases in humans and animal models. The journal publishes original contributions in both non-malignant and malignant hematological diseases, encompassing clinical and basic studies in areas such as hemostasis, thrombosis, immunology, blood banking, and stem cell biology. Clinical translational reports highlighting innovative therapeutic approaches for the diagnosis and treatment of hematological diseases are actively encouraged.The American Journal of Hematology features regular original laboratory and clinical research articles, brief research reports, critical reviews, images in hematology, as well as letters and correspondence.